Lissemore, Jennifer I.
Bhandari, Apoorva
Mulsant, Benoit H.
Lenze, Eric J.
Reynolds, Charles F. III
Karp, Jordan F.
Rajji, Tarek K.
Noda, Yoshihiro
Zomorrodi, Reza
Sibille, Etienne
Daskalakis, Zafiris J.
Blumberger, Daniel M.
Article History
Received: 16 October 2017
Revised: 31 January 2018
Accepted: 8 May 2018
First Online: 17 May 2018
Competing interests
: JIL, AB, and RZ report no biomedical interests or conflicts. BHM currently receives research funding from Brain Canada, the Centre for Addiction and Mental Health (CAMH) Foundation, the Canadian Institutes of Health Research (CIHR), Patient-Centered Outcomes Research Institute (PCORI), and the US National Institute of Health (NIH). During the last five years, he also received research support from Bristol-Myers Squibb (medications for a NIH-funded clinical trial), Eli-Lilly (medications for a NIH-funded clinical trial), and Pfizer (medications for a NIH-funded clinical trial). He directly own stocks of General Electric (less than $5000). EJL reports research funding (current/past) from Janssen, Alkermes, Acadia, Takeda, Lundbeck, Barnes Jewish Foundation, PCORI, and Taylor Family Institute for Innovative Psychiatric Research. CFR has received research support from the NIH, PCORI, the Center for Medicare and Medicaid Services, the American Foundation for Suicide Prevention, the Brain and Behavior Research Foundation, and the Commonwealth of Pennsylvania. Bristol Meyers Squib and Pfizer have provided pharmaceutical supplies for his NIH sponsored research. JFK received medication supplies from Indivior to support this investigator-initiated trial. He has also received medication supplies from Pfizer for investigator-initiated work. JFK receives research funding from NIH and PCORI. TKR receives research support from Brain Canada, Brain and Behavior Research Foundation, Canada Foundation for Innovation, the CIHR, Ontario Ministry of Health and Long-Term Care, Ontario Ministry of Research and Innovation, the NIH, and the W. Garfield Weston Foundation. YN has received equipment-in-kind support for an investigator-initiated study from Magventure Inc. He has also received research support from Otsuka Pharmaceutical Co., Ltd, Shionogi & Co., Ltd., and Meiji Seika Pharma Co., Ltd. YN has received research support from Meiji Yasuda Mental Health Foundation. ES has received support from NIH, CIHR, the Brain & Behavior Research Foundation (NARSAD) and the Campbell Family Mental Health Research Institute of CAMH. ES is co-inventor on a US provisional patent application that covers compounds modulating the function of GABA neurons. ZJD has received within the last 3 years both research and equipment in-kind support for an investigator-initiated study through Brainsway Inc and Magventure Inc. ZJD has also received monies for participation on an advisory board from Sunovion Inc. Finally, ZJD owns > $10,000 (CAD) in stock of Biogen Inc. DMB has received research support from CIHR, NIH, Brain Canada and the Temerty Family through the CAMH Foundation and the Campbell Research Institute. He receives research support and in-kind equipment support for an investigator-initiated study from Brainsway Ltd. and he is the site principal investigator for three sponsor-initiated studies for Brainsway Ltd. He also receives in-kind equipment support from Magventure for an investigator-initiated study. He receives medication supplies for an investigator-initiated trial from Indivior.